GGM's 2016 China and Asia-Pacific Ophthalmology market intelligence program subscriptions are now available, giving you access to accurate market data, reliable buyer insights and private custom research topics. Covering Ophthalmology Equipment, IOLs and Hospital Services, the service includes country level data and analysis on: Market opportunities, competitive gaps, surgeon perceptions, installed base, usage, market volume and value size, prices, detailed segmentation, regulations and reimbursement, market players, future outlook, positioning recommendations and more. 

 Articles

29-Sep-16 Plans to turn an unused shoe factory in the US city of Auburn, Maine, into a medical tourism centre for Chinese patients are faltering. Chinese investment company Miracle Enterprise plans a 200-room recovery centre for wealthy Chinese seeking medical care at the Central Maine Medical Center. Miracle Enterprise needs to find USD40 mn, but is struggling to attract investors. [image: IMTJ]

29-Sep-16 Chinese companies have announced more than USD5.2 bn of overseas healthcare acquisitions in 2016, a 15-fold jump from 2012. "Even though China’s pharmaceutical industry is still in the middle of consolidation and price wars, we hope to escape from this and do more work in terms of innovation and internationalization," said Shao Yan, CEO of China Grand Pharma. [image: China Grand Pharmaceutical and Healthcare Holdings Ltd]

28-Sep-16 With the active ingredients in Traditional Chinese Medicine (TCM) now far better understood than ever before, a new range of hybrid TCM/Western treatments are wooing even the most cynical with their efficacy and lack of side-effects. Advances in research and development have enabled companies to integrate many of TCM's treatments and protocols with the latest technology and medical understanding. [image: HKTDC Research]